🇺🇸 FDA
Patent

US 9072763

Methods and compositions for treating inflammatory bowel disease

granted A61KA61K31/395A61K31/435

Quick answer

US patent 9072763 (Methods and compositions for treating inflammatory bowel disease) held by RedHill Biopharma Ltd. expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/395, A61K31/435, A61K31/438, A61K31/44